U.S. COPD Market - Therapeutic Overview and Patient Outlook

U.S. COPD Market - Therapeutic Overview and Patient Outlook

 

RELEASE DATE
18-Jun-2007
REGION
North America
Research Code: N165-01-00-00-00
SKU: HC02030-NA-MR_07345
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02030-NA-MR_07345

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Disease Overview

  • Introduction
  • Disease Definition
  • Symptoms
  • Risk Factors
  • Diagnosis
  • Treatments
  • Drug Delivery Methods
  • Disease Statistics
  • Competitive Structure

Patient Outlook

  • Patient Forecasts

General Market Trends

  • Challenges
  • Strategic Recommendations for Challenges
  • Market Drivers
  • Market Restraints
This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N165-01-00-00-00
Is Prebook No